Back to dashboard
MedicaidAdministrativeLow impact

***June 2025 DUR Board Newsletter***

Connecticut Medicaid (HUSKY Health)·CT · Family Medicine, Internal Medicine, Cardiology +1 more·Provider Bulletin
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This is an educational newsletter about olmesartan-induced sprue-like enteropathy, a rare but serious side effect of the ARB medication olmesartan that causes chronic diarrhea and weight loss. The bulletin provides clinical information for healthcare providers but does not establish new billing, coverage, or administrative requirements.

Action Required

Action needed
No billing action required - this is educational content only. Providers should be aware of this rare but serious side effect when prescribing olmesartan and consider discontinuation if patients present with chronic diarrhea and weight loss.

Related policy hubs